Results 71 to 80 of about 761 (100)

Drug repurposing to overcome antimicrobial resistance : the story of fingolimod and etrasimod

Infectious diseases, once manageable with antibiotics, are reemerging as challenging threats to public health due to a marked increase in antibiotic resistance.
Zore, Matej
core  

Targeted Therapies in Inflammatory Bowel Disease: Mechanisms, Comparative Evidence, and Clinical Translation. [PDF]

J Clin Med
Pavel C, Popa A, Ilie M, Plotogea OM, Dascalu RI, Cabel T, Gunsahin D, Tincu I, Gaspar B, Pavel LE, Oaie A.   +10 more
europepmc   +1 more source

Assessment and Impact of Age on the Safety and Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From the ELEVATE UC Clinical Program. [PDF]

Inflamm Bowel Dis
Lichtenstein GR, Allegretti JR, Loftus EV, Irving PM, Banerjee R, Charabaty A, Kuehbacher T, Bananis E, Woolcott JC, Dalam AB, Lazin K, Keating M, McDonnell A, Danese S.   +13 more
europepmc   +1 more source

Advancing Early Clinical Trials: The Transformative Potential of Decentralized Designs and Digital Technologies in Phase 1 Clinical Trial. [PDF]

Clin Pharmacol Ther
Malhotra BK, Kunjom Mfopou J, Huyghe I, Ryckmans P, Severs N, Plotka A, Tabner KC, Jennes MA, Bhuvanendran Nair A, Colzi A.   +9 more
europepmc   +1 more source

Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12. [PDF]

Inflamm Bowel Dis
Armuzzi A, Rubin DT, Schreiber S, Panés J, Fellmann M, Bartolome L, Gruben D, Goetsch M, Bhattacharjee A, Chaparro M, Dubinsky MC.   +10 more
europepmc   +1 more source

Etrasimod for alopecia areata: The scenario for a less extensive and moderate form. [PDF]

J Eur Acad Dermatol Venereol
Starace M.
europepmc   +1 more source

The Current Sphingosine 1 Phosphate Receptor Modulators in the Management of Ulcerative Colitis. [PDF]

J Clin Med
Choon XY, Yeo JH, White C, Sharma E, Samaan MA.   +4 more
europepmc   +1 more source

Sphingosine-1-Phosphate Receptor Modulators for the Treatment of Ulcerative Colitis: A Narrative Review Focusing on Safety. [PDF]

United European Gastroenterol J
Fantini MC, Centonze D, Giacobazzi G, Benemei S, Romeo E.   +4 more
europepmc   +1 more source

Editorial: Volume II: anti-inflammatory drug development focusing on immune mediated diseases. [PDF]

Front Pharmacol
Oliveira-Costa JF, Chaudhary A, Rawat SS, Prasad A.   +3 more
europepmc   +1 more source

Second-line treatment strategies of ulcerative colitis after conventional therapy failure: A systematic review and network meta-analysis of randomized controlled trials. [PDF]

PLoS One
Xu Y, Jiang W, Jiang M, Zhu B, Huo J, Wu M, Yang L.   +6 more
europepmc   +1 more source